Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT03707951 · ClinicalTrials.gov registry record · Phase 2
N-Acetylcysteine for Adolescent Alcohol Use Disorder
A Phase 2 study, sponsored by Medical University of South Carolina.
- Completed
- Registry status
- Phase 2
- Development phase
- 126
- Enrollment target
NCT03707951 is a Phase 2 study that has completed, run by Medical University of South Carolina. The registered enrollment target is 126 participants.
The verdict
NCT03707951, a Phase 2 study, has completed, sponsored by Medical University of South Carolina.
- COMPLETED
- Registry status
- Phase 2
- Development phase
- 126 participants
- Enrollment target
Study Summary
This is a 8-week randomized, placebo-controlled trial testing the effects of N-acetylcysteine (NAC), on a platform of weekly evidence-based brief alcohol intervention for 120 adolescents with alcohol use disorder (AUD). The primary efficacy endpoint is reduction in alcohol use (total standard drinks), compared between NAC and placebo groups.
Interventions
- DRUG Placebo oral capsule
- DRUG N-acetylcysteine
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 126 participants |
| Start Date | 2019-02-27 |
| Est. Completion | 2024-02-26 |
| Phase | Phase 2 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT03707951
The ClinicalTrials.gov registry entry for NCT03707951 describes a study currently listed as completed, categorized as Phase 2. The registered enrollment target is 126 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Medical University of South Carolina, which has 755 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 2 interventions - of which Placebo oral capsule is the first listed.
NCT03707951 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT03707951 about?
NCT03707951 is a clinical study titled "N-Acetylcysteine for Adolescent Alcohol Use Disorder". This is a 8-week randomized, placebo-controlled trial testing the effects of N-acetylcysteine (NAC), on a platform of weekly evidence-based brief alcohol intervention for 120 adolescents with alcohol use disorder (AUD). The primary efficacy endpoint is reduction in alcohol use (total standard drinks...
What is the current status of trial NCT03707951?
This trial is currently completed. It is a Phase 2 study. The enrollment target is 126 participants. The study started on 2019-02-27. Estimated completion is 2024-02-26.
What interventions are being tested in trial NCT03707951?
The interventions under investigation include: Placebo oral capsule (DRUG), N-acetylcysteine (DRUG).
Who is sponsoring clinical trial NCT03707951?
This trial is sponsored by Medical University of South Carolina, which has 755 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.